Skip to content
Government Federal, Medical Health Aged Care

The ethical dilemmas of preventing the next pandemic

La Trobe University 3 mins read

 

 FOR IMMEDIATE RELEASE

   The ethical dilemmas of preventing the next pandemic 

Could protecting one group of people from disease, and exposing another to it, be the best way to prevent as many deaths as possible and reduce the impact of a future pandemic?  

A study led by some La Trobe academics says yes, but the ethical dilemmas it raises might not be worth it.  

Disease Modellers have determined an effective way to reduce the impact of infectious diseases like COVID-19 – but the results are likely to pose an ethical dilemma for decision and policy makers. 

The study, led by Dr Joel Miller, Associate Professor of Mathematics and Statistics at La Trobe University, found that locking down the most at-risk group of people for a significant period, while simultaneously promoting infection in other groups in order to reach herd immunity, could be the best way to protect the high-risk groups.  

However, increasing the exposure of one group to a disease would create an ethical dilemma and potentially result in the most disadvantaged groups in the community – usually with the least political power – becoming the highly-infected group. 

“With COVID-19, the elderly were at high risk, so if we were to isolate them for a period of time, during which we enact policies that would cause younger age groups to interact more (not less), then the disease likely would not spread well once the isolations were lifted and interactions returned to normal,” Dr Miller said. 

“If we set aside the question of whether such a strategy is logistically feasible, in a sense this is an optimal intervention.  However, there are major ethical challenges that result – the intervention makes younger age groups worse off from an infection point of view.   

“Our goal in this paper is not to advocate for such a policy, but rather to highlight some ethical dilemmas that emerge from intervention strategies. It is important that policy makers recognise the trade-offs that an ‘optimal’ strategy might require.” 

The paper, Ethical dilemma arises from optimising interventions for epidemics in heterogeneous populations, has been published in Royal Society Interface and includes co-authors from La Trobe University, University of Melbourne and Northeastern University London. 

The researchers used “SIR and SIR-like models” which assume individuals in the population are Susceptible, Infected, or Recovered (with immunity) to study the optimal intervention, such as lockdowns and isolation, required in a community to reduce and delay the peak of an epidemic, and ensure there is no further risk of a future epidemic or second wave of infections. They explored what would happen if different groups within the population, such as different age groups, have different risk factors for severe infection. 

Using data from a Netherlands survey that determined how often people in different age groups came into contact with each other, the researchers simulated different scenarios to determine the best outcome for an entire population, assuming that an intervention altering the contacts would be in place for a limited time. 

It found that if the intervention did not reduce contacts sufficiently then a large epidemic would occur. However, if the intervention reduced contacts too much there would be a modest epidemic and once the intervention was lifted, many individuals would still be susceptible, and a second wave would occur.  

The optimal intervention occurs where contacts are reduced so that the initial epidemic is as small as possible while still infecting enough people to prevent a second wave. 

If there are multiple groups with varying risk, the same general principles apply, but sometimes the optimal intervention increased the number of infections in the lower-risk groups to reduce the risk of a second wave once the intervention would end. 

“This calls for a discussion around the ethics of subjecting certain groups to a higher rate of disease incidence, and the feasibility of this policy,” the study says. 

Dr Miller said this was the first study to consider the ethical implications of an increase in infections as a strategy for optimal outcomes, without the use of vaccines. 

However, Dr Miller says choosing which groups to lockdown, and those in which to actively promote infection, was an ethical dilemma for governments and the community. 

“Mathematical models of epidemics can throw light on possible choices of policy and may even help us pick the ones that lead to optimal outcomes. But the decisions made by policymakers are intertwined with political will, their popularity, and social attitudes,” the study says. 

“These eventually determine whether a particular intervention is favoured by a decision-making body. 

“Disadvantaged groups, across the world, do not exercise sufficient political power to represent their interests in decision-making bodies. In such a case, a decision-making body may find it convenient to subject a disadvantaged group to a higher final size in order to decrease the net final size for the whole population and achieve herd immunity. 

“The intervention strategy presented here, always carries such risks with it; and representation of disadvantaged groups thus becomes essential, especially for a policy such as this one.” 

Read the paper here 

Dr Joel Miller is available for interviews contact [email protected]  or

Sue Smethurst

Senior Manager, Media & Communications 

0418 643 520 or [email protected] 

 

 

 

 

 

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 17/12/2025
  • 06:00
Leukaemia Foundation

Leukaemia Foundation welcomes South Australian Government commitment to establish dedicated CAR T therapy service

The Leukaemia Foundation has welcomed the announcement by theMalinauskas Labor Government that South Australia is establishing a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer – marking a major advancement in cancer care in the State. The new service, expected to commence by mid-2026, will significantly improve access to this highly specialised, life-saving treatment and reduce the need for South Australians to travel interstate for care. Leukaemia Foundation Chief Executive Officer Chris Tanti said the announcement represented a huge win for blood cancer patients and their families. “This is a landmark step…

  • Medical Health Aged Care
  • 17/12/2025
  • 01:10
WW International Inc.

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that lastNEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience bringing together comprehensive support for members on GLP-1 medications, personalised nutrition, behavioural support, coaching, and community within a redesigned app and digital platform. Built for a new era of weight management and long-term health, the new integrated offering delivers coordinated, evidence-based…

  • Medical Health Aged Care
  • 16/12/2025
  • 12:11
Esco Aster Pte. Ltd.

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

SINGAPORE–BUSINESS WIRE– Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.